Delivery Order SPE2DB20D3103-SPE2DB21FQ2L4

Award Date 9/13/21
Potential Completion Date 9/14/21
Potential Value $2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,583.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4567949127 - YUVAFEM 10 MCG VAGINAL INSERT 18S, with a final completion date of April 18, 2025. This is a firm fixed-price delivery order contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order with a Firm Fixed Price valued at $1,708.32. The contract, issued by the Defense Logistics Agency (DLA) Troop Support Medical, is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 18S, a pharmaceutical product. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026....
This federal contract award, valued at $9,159.27, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of YUVAFEM 10 MCG vaginal inserts. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,265.46 delivery order contract is for the delivery of YUVAFEM 10 MCG vaginal inserts to support federal healthcare programs. The contract has a firm fixed price pricing type and an ultimate completion date of February 28, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,479.70, is for the delivery of YUVAFEM 10 MCG VAGINAL INSERT 8S medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,124.90, is a Firm Fixed Price Delivery Order for the supply of 4565056249 YUVAFEM 10 MCG VAGINAL INSERT 18S. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,423.70 for the supply of YUVAFEM 10 MCG VAGINAL INSERT 18S medical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,124.13, is for the delivery of 4567268628 YUVAFEM 10 MCG VAGINAL INSERT 18S medical supplies. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This federal contract award, valued at $1,543.47, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of YUVAFEM 10 MCG VAGINAL INSERT 8S, a medical product, to support military healthcare programs. The contract is not designated as a set-aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, with a ceiling value of $11,557.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of YUVAFEM 10 MCG vaginal inserts, a critical medical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB21FQ2L4
    Delivery Order

This federal contract award, valued at $2,045.87, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of 4554754840 YUVAFEM 10 MCG vaginal inserts. This contract represents a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating full and open competition.

Generated 2/27/25, 11:18 AM